Physician profile
Benoit Kindo
NPI 1356081913
$5,275.74
in general payments reported to CMS, 2019-2025
9 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,325 · 2023: $1,990 · 2024: $642 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,723 · Food and Beverage: $1,589 · Education: $639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,722.89 |
| Food and Beverage | $1,588.80 |
| Education | $638.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,101.78 | 2023-2025 | Actis, Na |
| Mid-Atlantic Surgical Systems, LLC | $1,354.03 | 2022-2024 | |
| Globus Medical, INC. | $752.95 | 2024-2025 | Alif, Xlif, Distal Femur Plate System |
| Stryker Corporation | $749.50 | 2022-2025 | Mako, T2 Alpha, Blueprint Patient Specific Instrumentation |
| Integra Lifesciences Corporation | $149.51 | 2023 | Tenoglide, Integra, Primatrix |
| Si-Bone, INC. | $70.42 | 2024 | |
| Medtronic, INC. | $59.20 | 2023 | Aquamantys(Tm) |
| Solventum Corporation | $22.58 | 2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C. Veraflo |
| Kci USA, INC. | $15.77 | 2023 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benoit Kindo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.